NKG2D-based CAR T-cells

BIOLOGICAL2 trials

Sponsors

Jiujiang University Affiliated Hospital, Fudan University

Conditions

Colon CancerGlioblastomaHepatocellular CarcinomaMedulloblastoma

Phase 1

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

WithdrawnNCT04270461

Jiujiang University Affiliated HospitalColon Cancer, Glioblastoma, Hepatocellular Carcinoma +1

Start: 2020-03-17End: 2020-10-17Updated: 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Fudan UniversityColon Cancer, Glioblastoma, Hepatocellular Carcinoma +1

Start: 2021-03-01End: 2023-12-01Target: 3Updated: 2021-11-23